Citation Impact

65 standout
Sub-graph 1 of 24

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
2 intermediate papers

Works of Thomas Van Looy being referenced

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models
2014

Author Peers

Author PRM Gastroenterology Neurology Molecular Biology Last Decade Papers Cites
Thomas Van Looy 225 194 82 93 18 340
Hrvoje Gotovac 2 29 449
Xiaoping Liang 13 17 416
J. M. Z. Kamau 1 5 23 287
Claudia Squire 2 3 18 355
Yu‐Chee Tseng 1 34 452

All Works

Loading papers...

Rankless by CCL
2026